← Oncology Approval Tracker

FDA DECISION ·

Qinlock

ripretinib · Deciphera Pharmaceuticals

FDA approvalNew therapyGastrointestinal stromal tumor
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with advanced gastrointestinal stromal tumor previously treated with at least three kinase inhibitors, including imatinib.

LAMPGEN ANALYSIS

Why it matters

Added a later-line KIT and PDGFRA inhibitor for heavily pretreated disease.

What research teams should watch

Reconcile prior kinase inhibitor sequences and plan dermatology and cardiac monitoring.

PRIMARY RECORDS

Sources